Data / Form D filings / Acuamark Diagnostics, Inc.
Acuamark Diagnostics, Inc.: Form D filings
Acuamark Diagnostics, Inc., a health care company in New York, NY, filed 4 Form D notices with the SEC between 2016 and 2024. The latest, on June 4, 2024, reports $4.9 million sold of a $12 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 AVENUE OF THE AMERICAS, FLOOR 13 (C/O JLABS), New York, NY, 10020
- Phone
- (646) 640-7865
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1685619
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | New notice | $11,999,983 | $4,941,620 | $7,058,363 | 20 | May 22, 2024 | sec.gov |
| Apr 6, 2022 | New notice | $13,648,253 | $11,623,242 | $2,025,011 | 41 | Mar 21, 2022 | sec.gov |
| Sep 25, 2019 | New notice | $5,315,765 | $2,289,501 | $3,026,264 | 29 | Sep 10, 2019 | sec.gov |
| Nov 17, 2016 | New notice | $1,700,000 | $1,478,834 | $221,166 | 20 | Sep 1, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bernard Peperstraete | Executive Officer, Director | |
| Cedric Francois | Director | |
| Claudio Del Vecchio | Director | |
| Vanja Vuletic | Director | |
| William Gedale | Director | |
| Giulia Kennedy | Director |
Other health care companies in New York that filed recently
- MOCEAN HOLDINGS Corp $1.5 million · Oct 27, 2026
- Frictionworx Inc. $40,000 · Oct 13, 2026
- Atmos Clinic, Inc. $6 million · Oct 8, 2026
- PreciseDx, Inc. $3.7 million · Oct 7, 2026
- Amani Therapeutics, Inc. $35 million · Oct 1, 2026
- Click Therapeutics, Inc. $50 million · Oct 1, 2026
Every Form D from the week of Jun 3, 2024 · All recent filings in New York · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Acuamark Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.